Response to Pegylated Interferon Plus Ribavirin in Patients with Hepatitis C Virus Genotype 6a Infection from Guangdong and Guangxi Province of China
Aim. Our aim is to survey the treatment effect of PEG-IFN plus ribavirin in patients infected with HCV genotype 6a in Guangdong and Guangxi province of China and investigate best course of antiviral treatment for patients with HCV-6a infection. Methods. 515 eligible patients received subcutaneous 18...
Saved in:
| Main Authors: | Wangxia Tong, Jianyun Zhu, Ning Luo, Xiaohua Yang, Zhiying Lei, Xiaoliang Huang, Zhixin Zhao, Xiaohong Zhang, Zhiliang Gao, Zhonghua Jiang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Gastroenterology Research and Practice |
| Online Access: | http://dx.doi.org/10.1155/2016/5397407 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of triple therapy with recombinant interleukin-1β, recombinant interferon-α and ribavirin in patients with chronic hepatitis C, genotype 1 infection, the non-responders to previous treatment with interferon and ribavirin
by: Yu. V. Lobzin, et al.
Published: (2014-09-01) -
Pegylated Interferon Alpha for Chronic Hepatitis B Virus Infection
by: Joana Vasconcelos, et al.
Published: (2022-01-01) -
Successful treatment of hairy cell leukaemia with pegylated interferon-alpha-2A
by: Kata Ferenczi, et al.
Published: (2025-05-01) -
Sequence variation of the HVR1 region of Hepatitis C virus in response to interferon-α and ribavirin treatment
by: Ahmed Ali Al-Qahtani, et al.
Published: (2011-05-01) -
Is Combined Bulevirtide and Pegylated Interferon Therapy for Chronic Hepatitis D Superior over Bulevirtide Monotherapy?
by: V. E. Syutkin, et al.
Published: (2020-09-01)